These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26026911)

  • 1. Piperlongumine is a novel nuclear export inhibitor with potent anticancer activity.
    Niu M; Xu X; Shen Y; Yao Y; Qiao J; Zhu F; Zeng L; Liu X; Xu K
    Chem Biol Interact; 2015 Jul; 237():66-72. PubMed ID: 26026911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRM1 is a direct cellular target of the natural anti-cancer agent plumbagin.
    Liu X; Niu M; Xu X; Cai W; Zeng L; Zhou X; Yu R; Xu K
    J Pharmacol Sci; 2014; 124(4):486-93. PubMed ID: 24739265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperlongumine selectively suppresses ABC-DLBCL through inhibition of NF-κB p65 subunit nuclear import.
    Niu M; Shen Y; Xu X; Yao Y; Fu C; Yan Z; Wu Q; Cao J; Sang W; Zeng L; Li Z; Liu X; Xu K
    Biochem Biophys Res Commun; 2015 Jul; 462(4):326-31. PubMed ID: 25979358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export.
    Daelemans D; Afonina E; Nilsson J; Werner G; Kjems J; De Clercq E; Pavlakis GN; Vandamme AM
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14440-5. PubMed ID: 12374846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperlongumine (piplartine) as a lead compound for anticancer agents - Synthesis and properties of analogues: A mini-review.
    Piska K; Gunia-Krzyżak A; Koczurkiewicz P; Wójcik-Pszczoła K; Pękala E
    Eur J Med Chem; 2018 Aug; 156():13-20. PubMed ID: 30006159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells.
    Jarvius M; Fryknäs M; D'Arcy P; Sun C; Rickardson L; Gullbo J; Haglund C; Nygren P; Linder S; Larsson R
    Biochem Biophys Res Commun; 2013 Feb; 431(2):117-23. PubMed ID: 23318177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and mechanism investigation of a new piperlongumine derivative as a potent anti-inflammatory agent.
    Sun LD; Wang F; Dai F; Wang YH; Lin D; Zhou B
    Biochem Pharmacol; 2015 Jun; 95(3):156-69. PubMed ID: 25850000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents.
    Wu Y; Min X; Zhuang C; Li J; Yu Z; Dong G; Yao J; Wang S; Liu Y; Wu S; Zhu S; Sheng C; Wei Y; Zhang H; Zhang W; Miao Z
    Eur J Med Chem; 2014 Jul; 82():545-51. PubMed ID: 24937186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraphysiological nuclear export signals bind CRM1 independently of RanGTP and arrest at Nup358.
    Engelsma D; Bernad R; Calafat J; Fornerod M
    EMBO J; 2004 Sep; 23(18):3643-52. PubMed ID: 15329671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of multiple nuclear export sequences in Fanconi anemia group A protein that contribute to CRM1-dependent nuclear export.
    Ferrer M; Rodríguez JA; Spierings EA; de Winter JP; Giaccone G; Kruyt FA
    Hum Mol Genet; 2005 May; 14(10):1271-81. PubMed ID: 15790592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action.
    Van Neck T; Pannecouque C; Vanstreels E; Stevens M; Dehaen W; Daelemans D
    Bioorg Med Chem; 2008 Nov; 16(21):9487-97. PubMed ID: 18835718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Horner-Wadsworth-Emmons approach to piperlongumine analogues with potent anti-cancer activity.
    Han LC; Stanley PA; Wood PJ; Sharma P; Kuruppu AI; Bradshaw TD; Moses JE
    Org Biomol Chem; 2016 Aug; 14(31):7585-93. PubMed ID: 27443386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome.
    Bosc E; Nastri J; Lefort V; Valli M; Contiguiba F; Pioli R; Furlan M; Bolzani VDS; El Amri C; Reboud-Ravaux M
    Biochem Biophys Res Commun; 2018 Feb; 496(3):961-966. PubMed ID: 29355526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent.
    Tripathi SK; Biswal BK
    Pharmacol Res; 2020 Jun; 156():104772. PubMed ID: 32283222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shuttling of the human cytomegalovirus transactivator protein pUL69.
    Lischka P; Rosorius O; Trommer E; Stamminger T
    EMBO J; 2001 Dec; 20(24):7271-83. PubMed ID: 11743003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel non-trimethoxylphenyl piperlongumine derivatives selectively kill cancer cells.
    Zhang Y; Ma H; Wu Y; Wu Z; Yao Z; Zhang W; Zhuang C; Miao Z
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2308-2312. PubMed ID: 28434764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-catenin can bind directly to CRM1 independently of adenomatous polyposis coli, which affects its nuclear localization and LEF-1/beta-catenin-dependent gene expression.
    Ki H; Oh M; Chung SW; Kim K
    Cell Biol Int; 2008 Apr; 32(4):394-400. PubMed ID: 18262809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRM1 mediates nuclear export of HDAC7 independently of HDAC7 phosphorylation and association with 14-3-3s.
    Gao C; Li X; Lam M; Liu Y; Chakraborty S; Kao HY
    FEBS Lett; 2006 Sep; 580(21):5096-104. PubMed ID: 16956611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preformulation Studies on Piperlongumine.
    Aodah A; Pavlik A; Karlage K; Myrdal PB
    PLoS One; 2016; 11(3):e0151707. PubMed ID: 26982320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRM1 inhibitor S109 suppresses cell proliferation and induces cell cycle arrest in renal cancer cells.
    Liu X; Chong Y; Liu H; Han Y; Niu M
    Korean J Physiol Pharmacol; 2016 Mar; 20(2):161-8. PubMed ID: 26937212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.